Trial Profile
Examination of Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With ENEAS.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2018
Price :
$35
*
At a glance
- Drugs Enalapril/nitrendipine (Primary)
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 01 Mar 2010 New trial record